Phibro Animal Health (PAHC) Receivables (2013 - 2026)

Phibro Animal Health's Receivables history runs 14 years deep, the most recent figure standing at $221.5 million for Q1 2026.

• In Q1 2026, Receivables rose 12.16% year-over-year to $221.5 million; the TTM figure through Mar 2026 stood at $221.5 million (up 12.16% YoY), while the FY2025 annual figure was $228.0 million, up 33.39% from the prior year.
• Receivables was $221.5 million for Q1 2026 at Phibro Animal Health, up from $215.9 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $228.0 million in Q2 2025 to a low of $142.7 million in Q3 2022.
• Historically, Receivables has averaged $176.5 million across 5 years, with a median of $165.1 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Receivables dropped 2.44% in 2023, then jumped 35.53% in 2025.
• A 5-year view of Receivables shows it stood at $151.8 million in 2022, then fell by 0.79% to $150.6 million in 2023, then increased by 27.33% to $191.8 million in 2024, then grew by 12.56% to $215.9 million in 2025, then advanced by 2.63% to $221.5 million in 2026.
• The last three Receivables figures came in at $221.5 million (Q1 2026), $215.9 million (Q4 2025), and $217.9 million (Q3 2025), per Business Quant data.